The resulting BACE1 siRNA-loaded EVs effectively down-regulated BACE1 mRNA in the mouse brain and alleviated Alzheimer’s disease symptoms [82]. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.